Effects of Electrical Muscle Stimulation on Waist Circumference in Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02970812 |
|
Recruitment Status :
Completed
First Posted : November 22, 2016
Results First Posted : December 4, 2018
Last Update Posted : June 10, 2021
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
This randomized, placebo-controlled, double-blind, controlled study was designed to investigate the efficacy of electrical muscle simulation (EMS) for treatment of waist circumference (WC) reduction in abdominal obese adults.
60 patients with abdominal obese, man with WC > 90 cm and woman with WC > 80 cm, received EMS as experimental group (EG) or transcutaneous electrical nerve stimulation (TENS) as control group (CG) 5 times a week for 12 weeks.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Abdominal Obesity | Device: Electrical Muscle Stimulation Device: Transcutaneous Electrical Nerve Stimulation | Not Applicable |
Background: This randomized, placebo-controlled, double-blind, controlled study was designed to investigate the efficacy of electrical muscle simulation (EMS) for treatment of waist circumference (WC) reduction in abdominal obese adults.
Methods: 60 patients with abdominal obese, man with WC > 90 cm and woman with WC > 80 cm, received EMS as experimental group (EG) or transcutaneous electrical nerve stimulation (TENS) as control group (CG) 5 times a week for 12 weeks.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 60 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Electrical Muscle Stimulation on Waist Circumference in Adults: A Randomized Controlled Trial |
| Study Start Date : | January 2015 |
| Actual Primary Completion Date : | May 2015 |
| Actual Study Completion Date : | September 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Electrical Muscle Stimulation
Electrical Muscle Stimulation (EMS) program was consisted of warm-up, warm-down, contraction and relaxation. It was programed to be resemble to actual muscle action of voluntary exercise. To increase energy consumption as high intensity exercise, tripled the contraction duration. EMS group used Program 3 and regulated intensity though channel from 1 to 4.
|
Device: Electrical Muscle Stimulation
Participants were under EMS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back. |
|
Placebo Comparator: Transcutaneous Electrical Nerve Stimulation
Transcutaneous group used Transcutaneous Electrical Nerve Stimulation (TENS) which is the use of electric current produced to stimulate the sensory nerves to block pain signal. It is programed to applied currents regularly, once a second with a frequency of 1 Hz.
|
Device: Transcutaneous Electrical Nerve Stimulation
Participants were under TENS 5 times a week for 12 weeks. Pads were applied on participants' abdomen, rectus abdominis and external oblique abdominal muscle areas without any recent wound, infection, scar, and warts while lie on their back. |
- Waist Circumference [ Time Frame: 12 weeks ]Waist circumference was measured by a tape
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subject has abdominal obese seventy subjects between the age 18 and 65 years
- Abdominal obesity was defined as having a waist circumference (WC) >90 cm for men or WC >80 cm for women was defined based on the Asia-Pacific criteria of the International Diabetes Federation.
Exclusion Criteria:
- pregnant or breastfeeding, had taken any treatment for weight loss or any medication known to affect weight
- had a weight loss of 3% or more in the preceding 3 months, had undergone any major surgery during the 1 year prior to study commencement
- had any inserted metallic materials including a pacemaker.
- aspartate aminotransferase or alanine aminotransferase of 100 mg/dL or more
- serum creatinine of 1.5 mg/dL or more
- a history of coronary arterial disease or cerebrovascular disease, impairment of a major organ system, cancer, severe lung diseases, severe cerebral trauma, uncontrolled hypertension and psychiatric diseases including eating disorder, etc.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02970812
| Korea, Republic of | |
| Pusan National University Yangsan Hospital | |
| Yangsan, Gyeungsangnam-do, Korea, Republic of, 50612 | |
| Principal Investigator: | Sang Yeoup Lee | Pusan National University Yangsan Hospital |
| Responsible Party: | Sang Yeoup Lee, Professor, Pusan National University Yangsan Hospital |
| ClinicalTrials.gov Identifier: | NCT02970812 |
| Other Study ID Numbers: |
2003011 |
| First Posted: | November 22, 2016 Key Record Dates |
| Results First Posted: | December 4, 2018 |
| Last Update Posted: | June 10, 2021 |
| Last Verified: | May 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Obesity, Abdominal Obesity Overnutrition Nutrition Disorders |

